Califf Clears First Senate Hurdle, But FDA Abortion Pill Decision May Complicate Final Confirmation
Executive Summary
Republican opposition to Califf over the agency’s recent move to relax its Mifeprex restrictions is ominous since in order be confirmed as FDA commissioner he’ll need enough GOP votes to make up for Democratic opposition over his opioid track record and connections to the drug industry.
You may also be interested in...
Republicans Turn Their Backs On Califf
A visual comparison of Robert Califf’s US FDA Commissioner confirmation votes in 2016 and 2022.
Califf Limps Toward FDA Commissioner Confirmation
Final Senate vote on Robert Califf’s nomination to lead the US Food and Drug Administration is expected 15 February after Califf narrowly squeaked through a procedural vote. The final vote is expected to be even tighter.
Non-Opioid Pain Treatments Likely Not Eligible For Accelerated Approval, US FDA Says
Other expedited pathways like fast track, priority review or breakthrough could be appropriate, according to new draft guidance.